Elena Sophia Doll

Elena Sophia Doll

Auto-generated profile, based on publicly available information

Elena Sophia Doll

Institute of Medical Psychology, Heidelberg University Hospital, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Journal of Genetic Counseling
Verified
Journal Article
Open access
EDElena Sophia Doll
Elena Sophia Doll
JMJulia Mahal
Julia Mahal
KAKarla Karoline Sonne Kalinka Alex
Karla Karoline Sonne Kalinka Alex
SLSeraina Petra Lerch
Seraina Petra Lerch
SKStefan Kölker
Stefan Kölker
BDBeate Ditzen
Beate Ditzen
The advancement of genome sequencing technology and its potential application in newborn screening is being discussed in various countries. Genomic newborn screening (gNBS) can provide parents with information about their child's genetic susceptibility for known disorders. However, it also presents ethical and psychosocial challenges. This study was carried out with a view toward the possible introduction of gNBS in Germany. Due to the existing challenges, it is crucial to understand different perspectives of relevant groups in Germany before implementing gNBS. Four online focus groups were conducted with parents, patient representatives, and healthcare professionals to explore perceived opportunities and challenges, as well as needs regarding a potential gNBS program. Discussions with altogether 24 participants were semi‐structured using a pre‐defined interview guide. Sessions were audio‐visually recorded and transcripts were analyzed using a structuring qualitative content analysis combining both deductive and inductive methods. Participants expressed positive views about gNBS but also reservations about a gNBS program and posed requirements for operating conditions. One salient theme that emerged was hope for certainty through gNBS in the face of numerous uncertainties. The study complements the perspective of patient representatives, providing further insight into the subject matter. This is a valuable contribution as they possess a comprehensive understanding of the medical, psychological, and ethical considerations involved. Patient representatives placed particular emphasis on the advantages of avoiding a diagnostic odyssey and the significance of support systems. The results provide first insights into different views on gNBS in Germany. These views can inform the potential preparation of a gNBS program in Germany, particularly with regard to information and consent requirements. Implications for practice, such as informing and educating parents about gNBS during pregnancy, can be derived from the study.

19 February 2025 in Genetics in Medicine
Verified
Journal Article
Open access
EDElena Sophia Doll
Elena Sophia Doll
SLSeraina Petra Lerch
Seraina Petra Lerch
KSKatja Maria Schmalenberger
Katja Maria Schmalenberger
KAKarla Alex
Karla Alex
SKStefan Kölker
Stefan Kölker
BDBeate Ditzen
Beate Ditzen
This systematic review aims to identify the factors that influence parents' decisions regarding pediatric diagnostic genetic testing (DT) and predictive genetic testing (PT). These factors are integrated into a conceptual decision-making model. Implications for genetic counseling, research, and ethics were derived. PubMed, PsychInfo, WebofScience, and related references were searched for original publications between 2000 and 2023. The extracted factors were categorized using existing models. Of the 5843 publications, 56 met the inclusion criteria. The included studies differentiated between DT, traditional PT, and expanded PT and described factors affecting parental decisions to have the child genetically tested and to be informed about additional findings. Factors included (1) benefits/hopes, (2) worries/concerns, (3) values and beliefs, (4) individual circumstances, and (5) emotional states. Our work extends the existing empirical decision model of family decisions about genome sequencing to genetic testing in pediatrics in general, adding the categories of individual circumstances and emotional states. These factors can be further integrated into the Health Belief Model; the importance of emotional states is reflected in dual-process theories, such as the Fuzzy Trace Theory. Research is required on emotional states, differences between DT and PT, parents' decisions regarding result disclosure, and dyadic variables as decision-making predictors.

5 September 2025 in Ethik in der Medizin
Verified
Journal Article
Open access
PDF file
SSSascha Settegast
Sascha Settegast
KAKarla Karoline Sonne Kalinka Alex
Karla Karoline Sonne Kalinka Alex
NDNicola Dikow
Nicola Dikow
UMUlrike Mütze
Ulrike Mütze
ESElena Schnabel-Besson
Elena Schnabel-Besson
EWEva C. Winkler
Eva C. Winkler
Definition of problem: Newborn screening (NBS) is an internationally successful program for the secondary prevention of rare congenital diseases. At present, most of the target conditions in NBS are diagnosed by biochemical markers. Recent advances in genomic sequencing and in the bioinformatic evaluation of genetic variants will soon make it feasible however to expand NBS significantly by testing newborns directly for pathogenic variants. Yet, genomic newborn screening (gNBS) raises important ethical issues that require resolution, given that several pilot studies on gNBS implementation are already underway. Given a rapidly growing scholarly engagement with the ethics of gNBS, a more systematic and comprehensive mapping of the ethical issues and considerations relevant to gNBS is needed to move the debate forward at this point. Methods: In this integrative review, we survey the literature with the aim of delineating a conceptual framework for the ethics of gNBS, which organizes the ongoing debate and thereby provides guidance for further research. Here in Part II, we outline a tentative normative framework for the ethics of gNBS by systematizing the core ethical principles advanced in the literature and offer an original contribution to the debate beyond a mere survey of considerations by proposing a substantive interpretation of these principles and how they relate to each other in the gNBS context. We demonstrate the general utility of this framework for addressing the ethical issues involved in gNBS program design by drawing out its implications for some of the issues presented in Part I. Conclusion: In Part I, we formulated a requirement of informed consent for gNBS. Since newborns still lack a capacity for autonomous choice and informed consent, we approach gNBS program design through the question of what renders it ethically permissible for the child’s custodians to consent to gNBS in its name. Consequently, we discuss the authority of parents as surrogate decision-makers for their child, who are bound by a duty of care towards it. We substantiate this duty (a) by discussing several rights of the child, viz., its rights to informational self-determination, genetic ignorance, privacy, and an open future, and (b) by developing a specification of the best interest standard for children as the main principle that should guide and constrain both parental decision-making and gNBS program design. Finally, we consider concerns that gNBS could result in a harmful medicalization of healthy children.

31 January 2026 in Genetics in Medicine Open
Verified
Journal Article
Open access
EDElena Sophia Doll
Elena Sophia Doll
KAKarla Karoline Sonne Kalinka Alex
Karla Karoline Sonne Kalinka Alex
CMCarlotta Julia Mayer
Carlotta Julia Mayer
HBHeiko Brennenstuhl
Heiko Brennenstuhl
UMUlrike Mütze
Ulrike Mütze
JMJulia Mahal
Julia Mahal
This study assessed general attitudes toward genomic newborn screening (gNBS) among the German public. In a population-representative survey, we assessed self-rated prior knowledge of gNBS, newborn screening (NBS), and genome sequencing and perceived attitudinal and informational uncertainty and agreement with potential advantages and disadvantages of gNBS via paper-based questionnaire. Sociodemographic information was obtained through interviews. Analyses included descriptive statistics and multiple linear regressions. Respondents (N = 2504; ages 16-92) rated their prior knowledge as low, especially for gNBS compared with NBS. Informational uncertainty was higher among individuals with lower self-rated prior knowledge, lower educational attainment, and lower income, whereas attitudinal uncertainty showed no significant correlates with sociodemographic factors. Agreement with potential advantages of gNBS outweighed that of potential disadvantages. Higher self-rated prior knowledge and income predicted higher agreement with advantages. Right-leaning political views correlated with greater agreement with disadvantages. Overall, sociodemographic factors explained little variance. Perceptions of gNBS were predominantly positive, although marked by uncertainty and low prior knowledge. Although some sociodemographic differences emerged, their influence on attitudes was limited. Additional factors, such as personality traits, may help explain attitude differences. Given low prior knowledge and its association with support for gNBS, improving genetic literacy through diverse outreach strategies is essential to enhance public acceptance of gNBS in Germany.

19 May 2025 in Genetics in Medicine Open
Verified
Journal Article
Open access
JMJulia Mahal
Julia Mahal
CMCarlotta J. Mayer
Carlotta J. Mayer
SSSebastian Sailer
Sebastian Sailer
MWMelanie Wittenberg-Marangione
Melanie Wittenberg-Marangione
JTJohanna Tecklenburg
Johanna Tecklenburg
BDBeate Ditzen
Beate Ditzen
This study examined the effects of self-developed educational videos on patient satisfaction and the physician-patient relationship in genetic outpatient clinics. Patients with suspected hereditary breast and ovarian cancer (HBOC, n = 311) or requiring exome sequencing for syndromic conditions (SYN, n = 52) were randomized to experimental or control groups. Before their consultations, the experimental group viewed videos detailing relevant genetic information. Patient and physician satisfaction and the quality of the physician-patient interaction were then assessed using questionnaires. The videos were found to be understandable and useful. The video intervention did not affect patient or physician satisfaction scales or the physicians’ workload. However, there were significant interaction effects: The video intervention was associated with significantly lower satisfaction scores among patients with SYN. Additionally, in post-hoc tests, we partially found lower satisfaction with patient decision making, as well as increased physician workload in the SYN group compared with the HBOC group. Educational videos can improve patient satisfaction in HBOC consultations. In complex and less homogenous clinical situations, such as genetic consultation and testing for syndromic conditions, however, face-to-face physician-patient contact may be more appropriate to reduce stress and adequately address individual questions.

2 September 2025 in Ethik in der Medizin
Verified
Journal Article
Open access
PDF file
SSSascha Settegast
Sascha Settegast
KAKarla Karoline Sonne Kalinka Alex
Karla Karoline Sonne Kalinka Alex
NDNicola Dikow
Nicola Dikow
UMUlrike Mütze
Ulrike Mütze
ESElena Schnabel-Besson
Elena Schnabel-Besson
EWEva C. Winkler
Eva C. Winkler
Definition of problem: Newborn screening (NBS) is an internationally successful program for the secondary prevention of rare congenital diseases. At present, most of the target conditions in NBS are diagnosed by biochemical markers. Recent advances in genomic sequencing and in the bioinformatic evaluation of genetic variants will soon make it feasible however to expand NBS significantly by testing newborns directly for pathogenic variants. Yet, genomic newborn screening (gNBS) raises important ethical issues that require resolution, given that several pilot studies on gNBS implementation are already underway. Given a rapidly growing scholarly engagement with the ethics of gNBS, a more systematic and comprehensive mapping of the ethical issues and considerations relevant to gNBS is needed to move the debate forward at this point. Methods: In this integrative review, we survey the literature with the aim of delineating a conceptual framework for the ethics of gNBS, which organizes the ongoing debate and thereby provides guidance for further research. Here in Part I, we focus primarily on an exposition of the ethical issues and questions involved in gNBS program design. Conclusion: The ethical issues divide into issues regarding (1) the test itself and the selection of target conditions, (2) informed consent, and (3) genomic data generation, storage, and use. Regarding (1) we discuss several dimensions along which potential target conditions can differ and their ethical implications, and formulate some requirements on appropriate selection criteria with special regard to minimizing diagnostic and therapeutic uncertainty. Regarding (2) we discuss the need for informed consent, the structure and content of pre-test counseling (when, who, what, how), the suggestion of a tiered testing offer, and familial conflict. Regarding (3) we discuss liberal versus restrictive approaches to genomic data generation, parental consent to genomic raw data storage for further uses beyond the test, some candidate further uses, and the risk of abuse.